A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.

@article{SchiemannDelgado2012ALO,
  title={A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.},
  author={Jimmy Schiemann-Delgado and Haichen Yang and Christine de la Loge and Tracy J Stalvey and John Kendrick Jones and Daniel B Legoff and Mark Mintz},
  journal={Journal of child neurology},
  year={2012},
  volume={27 1},
  pages={80-9}
}
The objective of this study was to assess cognition and behavior in children (4-16 years; n = 103) with partial-onset seizures using the Leiter-R International Performance Scale and Achenbach Child Behavior Checklist. The study was a multicenter, open-label, noncomparative 48-week extension study (NCT00152516) of adjunctive levetiracetam (20-100 mg/kg/d, mean 50.2 mg/kg/d). Improvement from baseline in Leiter-R Memory Screen composite score at weeks 24 and 48 (mean [SD] change, +4.8 [12.6] and… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
21 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 21 extracted citations

Similar Papers

Loading similar papers…